MedX Health Corp
MDX.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 38.17% | 19.16% | -7.23% | 5.01% | -39.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 38.17% | 19.16% | -7.23% | 5.01% | -39.48% |
| Cost of Revenue | 38.09% | 26.75% | -12.46% | 7.66% | -18.10% |
| Gross Profit | 38.50% | 7.79% | 1.07% | 1.44% | -60.19% |
| SG&A Expenses | 31.78% | -2.82% | -12.18% | -30.25% | -30.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.06% | -0.95% | -11.07% | -20.90% | -25.86% |
| Operating Income | -24.35% | 3.59% | 11.73% | 24.81% | 23.43% |
| Income Before Tax | -63.50% | -18.99% | 2.76% | 21.63% | 41.78% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -63.50% | -18.99% | 2.76% | 21.63% | 41.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -63.50% | -18.99% | 2.76% | 21.63% | 41.78% |
| EBIT | -24.35% | 3.59% | 11.73% | 24.81% | 23.43% |
| EBITDA | -25.80% | 3.16% | 11.37% | 24.98% | 24.27% |
| EPS Basic | -48.89% | 2.40% | 25.81% | 44.13% | 58.33% |
| Normalized Basic EPS | -22.06% | 15.56% | 33.94% | 50.00% | 49.63% |
| EPS Diluted | -48.89% | 2.40% | 25.81% | 44.13% | 58.33% |
| Normalized Diluted EPS | -22.06% | 15.56% | 33.94% | 50.00% | 49.63% |
| Average Basic Shares Outstanding | 10.25% | 16.41% | 24.21% | 35.22% | 39.04% |
| Average Diluted Shares Outstanding | 10.25% | 16.41% | 24.21% | 35.22% | 39.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |